CRISPR Therapeutics has seen its stock price decline over the past year, trading significantly below Wall Street's price targets. Analysts predict potential gains, with one projecting an 86% upside based on the company's gene therapy product, CASGEVY, which has shown strong reve…
AbbVie is nearing its 52-week high, driven by strong sales of SKYRIZI, its psoriasis and Crohn's disease treatment. However, potential risks to its stock price arise from market c…
Anavex Life Sciences is making strides in its Phase 3 planning for Alzheimer's disease with the FDA, having submitted clinical trial data and reporting a cash position of $118.3 m…
Zymeworks (NASDAQ:ZYME) shares increased nearly 4% in pre-market trading as investors prepared for a crucial FDA decision regarding zanidatamab, expected on August 25, 2026. The F…
Apnimed is preparing for a $160 million initial public offering on the Nasdaq to support the development of its lead therapy for obstructive sleep apnoea (OSA). The Massachusetts-…
Nvidia's venture arm, NVentures, has acquired 833,325 shares in Generate Biomedicines, valued at approximately $10.4 million. Generate is developing an AI-driven platform for drug…
The shift from injectable GLP-1 medications to oral pills presents a significant opportunity to improve diabetes and obesity treatment accessibility, particularly in the Global So…
A nonpartisan ethics watchdog has requested an investigation into Alicia Jackson, a high-ranking official at the Department of Health and Human Services, following allegations of…
In an ambitious move, RFK Jr. aims to ease access to unapproved peptide drugs, assuring patients they’ll receive a 'more controlled alternative' while keeping the actual safety of…
A Massachusetts woman is facing serious charges after allegedly performing unauthorized eyelid surgery that left her patient with permanent scars. Dingrui Wang, 34, is accused of…
A recently declassified CIA memo shows that Dr. Scott Gottlieb, a former FDA commissioner and current Pfizer board member, rejected findings from two California studies that indic…
This article discusses recent rulings from various U.S. courts, including the Fifth Circuit's dismissal of a drugmaker appeal against the Medicare drug negotiation program and the…